D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Broadcom
AVGO
|
+$596M |
| 2 |
Accenture
ACN
|
+$470M |
| 3 |
Intel
INTC
|
+$412M |
| 4 |
Adobe
ADBE
|
+$365M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$258M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.5B |
| 2 |
Apple
AAPL
|
+$1.02B |
| 3 |
Microsoft
MSFT
|
+$776M |
| 4 |
Netflix
NFLX
|
+$688M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$542M |
Sector Composition
| 1 | Technology | 26.84% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Financials | 10.39% |
| 4 | Healthcare | 9.6% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
AB InBev
BUD
$114B
| $2.36M | ﹤0.01% |
40,612
-53,546
| -57% | -$3.11M |
|
1577
iShares Core S&P Mid-Cap ETF
IJH
$101B
| $2.36M | ﹤0.01% |
+40,305
| New | +$2.36M |
|
1578
Greif
GEF
$3.59B
| $2.36M | ﹤0.01% |
41,003
+7,139
| +21% | +$410K |
|
1579
iShares Biotechnology ETF
IBB
$5.65B
| $2.35M | ﹤0.01% |
17,145
-58,024
| -77% | -$7.96M |
|
1580
EOG Resources
EOG
$64.5B
| $2.35M | ﹤0.01% |
+18,682
| New | +$2.35M |
|
1581
HealthEquity
HQY
$7.97B
| $2.35M | ﹤0.01% |
+27,226
| New | +$2.35M |
|
1582
First Trust NASDAQ Cybersecurity ETF
CIBR
$10.8B
| $2.35M | ﹤0.01% |
+41,593
| New | +$2.35M |
|
1583
LCI Industries
LCII
$2.43B
| $2.34M | ﹤0.01% |
+22,593
| New | +$2.34M |
|
1584
3D Systems Corporation
DDD
$286M
| $2.33M | ﹤0.01% |
759,024
+588,862
| +346% | +$1.81M |
|
1585
Cathay General Bancorp
CATY
$3.39B
| $2.33M | ﹤0.01% |
+61,687
| New | +$2.33M |
|
1586
SLM Corp
SLM
$5.86B
| $2.32M | ﹤0.01% |
111,648
-76,311
| -41% | -$1.59M |
|
1587
Saia
SAIA
$8.33B
| $2.32M | ﹤0.01% |
4,891
-32,243
| -87% | -$15.3M |
|
1588
Dimensional US Small Cap ETF
DFAS
$11.3B
| $2.31M | ﹤0.01% |
38,467
+29,874
| +348% | +$1.79M |
|
1589
NeoGenomics
NEO
$1.03B
| $2.31M | ﹤0.01% |
166,556
+21,268
| +15% | +$295K |
|
1590
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.67B
| $2.31M | ﹤0.01% |
131,624
-88,391
| -40% | -$1.55M |
|
1591
Lands' End
LE
$475M
| $2.3M | ﹤0.01% |
169,529
+4,675
| +3% | +$63.5K |
|
1592
Build-A-Bear
BBW
$971M
| $2.3M | ﹤0.01% |
91,097
-27,957
| -23% | -$706K |
|
1593
UGI
UGI
$7.47B
| $2.3M | ﹤0.01% |
100,382
-266,170
| -73% | -$6.1M |
|
1594
Tennant Co
TNC
$1.5B
| $2.3M | ﹤0.01% |
23,327
-7,134
| -23% | -$702K |
|
1595
Intrepid Potash
IPI
$389M
| $2.29M | ﹤0.01% |
97,921
-27,621
| -22% | -$647K |
|
1596
Matsons
MATX
$3.29B
| $2.29M | ﹤0.01% |
17,515
-35,334
| -67% | -$4.63M |
|
|
CIO
1597
City Office REIT
CIO
$280M
| $2.28M | ﹤0.01% |
458,628
+53,506
| +13% | +$266K |
|
1598
Cerence
CRNC
$450M
| $2.28M | ﹤0.01% |
805,444
+700,645
| +669% | +$1.98M |
|
1599
Vera Bradley
VRA
$61.5M
| $2.28M | ﹤0.01% |
363,975
+142,566
| +64% | +$892K |
|
1600
Constellation Brands
STZ
$24.6B
| $2.27M | ﹤0.01% |
8,821
-9,380
| -52% | -$2.41M |
|